Do Plus Therapeutics Inc (NASDAQ: PSTV) Fit In A Value Investing Philosophy?
Currently, there are 17.00M common shares owned by the public and among those 16.57M shares have been available to trade. The company’s stock has a 5-day price change of -18.64% and -44.36% over the past three months. PSTV shares are trading -43.39% year to date (YTD), with the 12-month market performance down to -65.00% lower. […]
Plus Therapeutics Inc (NASDAQ: PSTV) Has Another Chance To Impress You
Currently, there are 11.79M common shares owned by the public and among those 11.48M shares have been available to trade. The company’s stock has a 5-day price change of 156.23% and 44.44% over the past three months. PSTV shares are trading 24.35% year to date (YTD), with the 12-month market performance down to -21.43% lower. […]
Technical Outlook And Game Plan For Plus Therapeutics Inc (NASDAQ: PSTV)
Plus Therapeutics Inc (PSTV) concluded trading on Thursday at a closing price of $1.38, with 353.23 million shares of worth about $487.45 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -13.21% during that period and on March 20, 2025 the price saw a […]
Value Hunters: Look To Plus Therapeutics Inc (PSTV)
Currently, there are 5.90M common shares owned by the public and among those 5.75M shares have been available to trade. The company’s stock has a 5-day price change of 373.20% and 6.72% over the past three months. PSTV shares are trading 24.35% year to date (YTD), with the 12-month market performance down to -17.34% lower. […]
Technical Outlook And Game Plan For Plus Therapeutics Inc (NASDAQ: PSTV)
Plus Therapeutics Inc (PSTV) concluded trading on Thursday at a closing price of $1.44, with 345.99 million shares of worth about $498.23 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -4.64% during that period and on March 06, 2025 the price saw a […]
